Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on April 8, 2025
NEXCOM NSA 5200 Sets Benchmark for AI Security Threat Detection
EIN Presswire
·
April 8, 2025
Delivering Enhanced Cybersecurity with AI Acceleration and Scalable Solutions for Encrypted Networks FREMONT, CA, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- NEXCOM, a leading global supplier of network appliances, announced today the launch of …
Label N Learn: A Game-Changer for Teachers in Classroom Organization and Parent Engagement
EIN Presswire
·
April 8, 2025
The new Label N Learn app gives teachers an edge, streamlining classroom management and parent communication with simple labels and newsletters. NJ, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- Label N Learn, a new mobile application, is …
Clean Earth Rolls Out New Fleet Nationwide, Enhancing Sustainability and Service Efficiency
GlobeNewswire
·
April 8, 2025
New trucks feature innovative modular design and technology-driven advancements, enhancing safety, compliance, and customer service. KING OF PRUSSIA, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- Clean Earth, a division of Enviri Corporation (NYSE: NVRI) and a …
Regula Wins Gold in the Globee Awards for Cybersecurity for Its Complete Identity Verification Solution
GlobeNewswire
·
April 8, 2025
RESTON, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Regula, a global developer of forensic devices and identity verification (IDV) solutions, has received Gold in the 2025 Globee Awards for Cybersecurity. This marks Regula’s second consecutive year of winning …
SCYNEXIS to Present Preclinical Data on Second Generation IV/Oral Fungerp SCY-247 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
GlobeNewswire
·
April 8, 2025
JERSEY CITY, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of …
Vivex Biologics, Inc. Provides Enrollment Update for its ASCEND Study Examining Whether Supplementing Discs with VIA Disc NP™ Reduces Pain and/or Improves Function in Patients with Symptomatic Disc Degeneration
GlobeNewswire
·
April 8, 2025
MIAMI, April 08, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company has enrolled 50% of the patients in its ASCEND clinical trial for VIA Disc NPTM. The ASCEND study is a …
Aqua Security Achieves FedRAMP® High Authorization
GlobeNewswire
·
April 8, 2025
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- Aqua Security, the pioneer in cloud native security, announced today that it has achieved the Federal Risk and Authorization Management Program’s (FedRAMP®) high impact authorization status and is listed in the …
Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial
GlobeNewswire
·
April 8, 2025
MORRISVILLE, N.C., April 08, 2025 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, today announced the successful completion of its second FDA inspection, reaffirming the quality of its Direct-to-Patient Site for …
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session
GlobeNewswire
·
April 8, 2025
Analyses of MRI and VEP data confirm anatomical and physiological improvements, indicating remyelination and neuronal repair in the brains of MS patients treated with CNM-Au8 during the long-term extension of VISIONARY-MS Over 90% of participants who …
Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies
GlobeNewswire
·
April 8, 2025
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
GlobeNewswire
·
April 8, 2025
First pediatric patient shows encouraging early safety profile and meaningful improvement in visual function at one month A second pediatric patient was recently dosed, and the pediatric cohort is expected to complete enrollment in Q2 2025; initial data …
ProStar Announces Global Commercial Strategy with Radiodetection to Deliver Precision Utility Mapping
GlobeNewswire
·
April 8, 2025
GRAND JUNCTION, Colo., April 08, 2025 (GLOBE NEWSWIRE) -- ProStar® Holdings Inc., (“ProStar®” or “the Company”) (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00) the developers of PointMan®, Precision Mapping Solutions® is pleased to announce a Global Commercial …
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
GlobeNewswire
·
April 8, 2025
SEATTLE, April 08, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease …
Cycurion, Inc. Expands Partnership with Journal Technologies, Secures $22 Million Contract with State Police Agency
GlobeNewswire
·
April 8, 2025
FALLS CHURCH, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU), a trailblazer in advanced cybersecurity and information technology solutions, today announces an expanded partnership with Journal Technologies, a leading provider of case …
TransGlobal Assets Inc. (OTC: TMSH) Set to Transform Fintech and Dating with AI-Powered Platforms: Intelligent Debt Solutions and DateGuard
GlobeNewswire
·
April 8, 2025
AI-First Debt Solutions That Prioritize Human Wellness: Intelligent Debt Solutions leverages real-time behavioral analytics and ethical AI to offer highly personalized financial recovery pathways for individuals while boosting efficiency and empathy in …
FTC Solar Introduces Revolutionary Dual-Row Configuration for 1P Pioneer Tracker™: Industry’s Highest East-West Slope Tolerance for a linked tracker
GlobeNewswire
·
April 8, 2025
AUSTIN, Texas, April 08, 2025 (GLOBE NEWSWIRE) -- FTC Solar, a leading provider of cutting-edge solar tracker technology, is excited to unveil its latest innovation with the dual-row configuration for the 1P Pioneer Tracker™, setting a new standard in …
VR Resources Identifies Geochemical Trends from New Data on Copper-Gold Veins at Silverback Project, Ontario
GlobeNewswire
·
April 8, 2025
VANCOUVER, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) -- VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCBB: VRRCF), the "Company", or “VR”, is pleased to announce new data, and results of a comprehensive geochemical study, at its 100%-owned Silverback …
SIGA Declares Special Cash Dividend of $0.60 Per Share
GlobeNewswire
·
April 8, 2025
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on the company’s common …
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
GlobeNewswire
·
April 8, 2025
‒ Q1 2025 Unaudited Net Revenue of $39.0 million ‒ ‒ Expected Q1 Adjusted EBITDA above $22.5 million ‒ ‒ Q1 2025 Cash and Cash Equivalents of Approximately $77.5 million ‒ BERKELEY HEIGHTS, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: …
ZenaDrone Expands Domestic Manufacturing for US Commercial Customers and US Defense Without Needing to Increase Prices
GlobeNewswire
·
April 8, 2025
VANCOUVER, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS and …